With markets coming in to a volatile time of year, investors might be more interested in generating income rather than capital gains.
Bristol-Myers Squibb (BMY) has long been a staple of dividend investors and with the stock showing a low Beta of 0.22 and a high yield of 3.90%, it provides an attractive opportunity for savvy investors.